Prediction of malignant middle cerebral artery infarction by early perfusion- and diffusion-weighted magnetic resonance imaging - PubMed (original) (raw)
Prediction of malignant middle cerebral artery infarction by early perfusion- and diffusion-weighted magnetic resonance imaging
Götz J Thomalla et al. Stroke. 2003 Aug.
Abstract
Background and purpose: We tested the hypothesis that early diffusion- and perfusion-weighted MRI (DWI and PWI, respectively) allows the prediction of malignant middle cerebral artery (MCA) infarction (MMI).
Methods: Thirty-seven patients with acute MCA infarction and proximal vessel occlusion (carotid-T, MCA main stem) were studied by DWI, PWI, and MR angiography within 6 hours of symptom onset. Eleven patients developed MMI, defined by decline of consciousness and radiological signs of space-occupying brain edema. Lesion volumes were retrospectively defined as apparent diffusion coefficient <80% (ADC<80%) and time to peak >+4 seconds (TTP>+4s) compared with the unaffected hemisphere. ADC decrease within the infarct core (ADCcore) and relative ADC within the ADC<80% lesion (rADClesion) were measured. Neurological deficit at admission was assessed with the National Institutes of Health Stroke Scale (NIHSS).
Results: Patients with MMI showed larger ADC<80% (median, 157 versus 22 mL; P<0.001) and TTP>+4s (208 versus 125 mL; P<0.001) lesion volumes, smaller TTP/ADC mismatch ratio (1.5 versus 5.5; P<0.001), lower ADCcore values (290 versus 411 mm2/s; P<0.001), lower rADClesion (0.60 versus 0.66; P=0.001), higher frequency of carotid-T occlusion (64% versus 15%; P=0.006), and higher NIHSS score at admission (20 versus 15; P=0.001). Predictors of MMI were as follows for sensitivity and specificity, respectively: ADC<80% >82 mL, 87%, 91%; TTP>+4s >162 mL, 83%, 75%; TTP/ADC mismatch ratio <2.4, 80%, 79%; ADCcore <300 mm2/s, 83%, 85%; rADClesion <0.62, 79%, 74%; and NIHSS score at admission > or =19, 96%, 72%.
Conclusions: Quantitative analysis of early DWI and PWI parameters allows the prediction of MMI and can help in the selection of patients for aggressive tissue-protective therapy.
Comment in
- Editorial comment--Can we predict massive space-occupying edema in large hemispheric infarctions?
Wijman CA. Wijman CA. Stroke. 2003 Aug;34(8):1899-900. doi: 10.1161/01.STR.0000081986.02572.D5. Epub 2003 Jul 10. Stroke. 2003. PMID: 12855828 No abstract available.
Similar articles
- Prediction of malignant middle cerebral artery infarction by magnetic resonance imaging within 6 hours of symptom onset: A prospective multicenter observational study.
Thomalla G, Hartmann F, Juettler E, Singer OC, Lehnhardt FG, Köhrmann M, Kersten JF, Krützelmann A, Humpich MC, Sobesky J, Gerloff C, Villringer A, Fiehler J, Neumann-Haefelin T, Schellinger PD, Röther J; Clinical Trial Net of the German Competence Network Stroke. Thomalla G, et al. Ann Neurol. 2010 Oct;68(4):435-45. doi: 10.1002/ana.22125. Ann Neurol. 2010. PMID: 20865766 - Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke.
Arenillas JF, Rovira A, Molina CA, Grivé E, Montaner J, Alvarez-Sabín J. Arenillas JF, et al. Stroke. 2002 Sep;33(9):2197-203. doi: 10.1161/01.str.0000027861.75884.df. Stroke. 2002. PMID: 12215587 - Refining the perfusion-diffusion mismatch hypothesis.
Butcher KS, Parsons M, MacGregor L, Barber PA, Chalk J, Bladin C, Levi C, Kimber T, Schultz D, Fink J, Tress B, Donnan G, Davis S; EPITHET Investigators. Butcher KS, et al. Stroke. 2005 Jun;36(6):1153-9. doi: 10.1161/01.str.0000166181.86928.8b. Stroke. 2005. PMID: 15914768 Clinical Trial. - Malignant MCA Infarction: Pathophysiology and Imaging for Early Diagnosis and Management Decisions.
Heiss WD. Heiss WD. Cerebrovasc Dis. 2016;41(1-2):1-7. doi: 10.1159/000441627. Epub 2015 Nov 19. Cerebrovasc Dis. 2016. PMID: 26581023 Review. - Real-time diffusion-perfusion mismatch analysis in acute stroke.
Straka M, Albers GW, Bammer R. Straka M, et al. J Magn Reson Imaging. 2010 Nov;32(5):1024-37. doi: 10.1002/jmri.22338. J Magn Reson Imaging. 2010. PMID: 21031505 Free PMC article. Review.
Cited by
- Reduced mortality and severe disability rates in the SENTIS trial.
Schellinger PD, Shuaib A, Köhrmann M, Liebeskind DS, Jovin T, Hammer MD, Sen S, Huang DY, Solander S, Gupta R, Leker RR, Saver JL; SENTIS Trial Investigators. Schellinger PD, et al. AJNR Am J Neuroradiol. 2013 Dec;34(12):2312-6. doi: 10.3174/ajnr.A3613. Epub 2013 Jul 4. AJNR Am J Neuroradiol. 2013. PMID: 23828106 Free PMC article. Clinical Trial. - Near infrared spectroscopy: finding utility in malignant hemispheric stroke.
Carandang R, Krieger DW. Carandang R, et al. Neurocrit Care. 2007;6(3):161-4. doi: 10.1007/s12028-007-0023-y. Neurocrit Care. 2007. PMID: 17572858 Review. No abstract available. - ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes.
Sims JR, Gharai LR, Schaefer PW, Vangel M, Rosenthal ES, Lev MH, Schwamm LH. Sims JR, et al. Neurology. 2009 Jun 16;72(24):2104-10. doi: 10.1212/WNL.0b013e3181aa5329. Neurology. 2009. PMID: 19528517 Free PMC article. - Early complications of ischemic stroke.
van der Worp HB, Raaijmakers TW, Kappelle LJ. van der Worp HB, et al. Curr Treat Options Neurol. 2008 Nov;10(6):440-9. doi: 10.1007/s11940-008-0046-5. Curr Treat Options Neurol. 2008. PMID: 18990312 - Favorable vascular profile is an independent predictor of outcome: a post hoc analysis of the safety and efficacy of NeuroFlo Technology in Ischemic Stroke trial.
Schellinger PD, Köhrmann M, Liu S, Dillon WP, Nogueira RG, Shuaib A, Liebeskind DS; SENTIS Trial Investigators. Schellinger PD, et al. Stroke. 2013 Jun;44(6):1606-8. doi: 10.1161/STROKEAHA.111.000709. Epub 2013 Apr 2. Stroke. 2013. PMID: 23549132 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources